Tailored Mediterranean Lifestyle Education in Patients With Mild Cognitive Impairment

Sponsor
Queen's University, Belfast (Other)
Overall Status
Completed
CT.gov ID
NCT03265522
Collaborator
Wellcome Trust (Other)
15
1
3
26
0.6

Study Details

Study Description

Brief Summary

Evidence suggests that a Mediterranean diet can have a beneficial effect on brain health. Mild cognitive impairment (MCI) describes problems with brain function such as difficulty with day-to-day memory and concentration. It is at this stage that Mediterranean diet could prove beneficial in terms of prevention.

Previous research by Queens University investigated the opinions of patients with MCI and their care givers to inform the development of Mediterranean diet education material to encourage behaviour change. The study suggested that MCI patients lacked awareness of the link between Mediterranean diet and brain function, although were interested to learn more. Feedback on the developed educational material was positive although there were suggested improvements such as tailoring information to memory loss, a potential staged approach to delivery and adaptations to the material content.

This present study aims to pilot test refined educational material among MCI participants to evaluate the feasibility of encouraging dietary behaviour change among this patient group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: "ThinkMed" resource at baseline
  • Behavioral: Standard Care Control
  • Behavioral: "ThinkMed" resource (staged)
N/A

Detailed Description

This study aims to evaluate the feasibility of a theory-based, tailored Mediterranean lifestyle education intervention to encourage behaviour change in patients with MCI. The proposed study will be a 6 month RCT with a total of 60 MCI patients who will be randomised to 1 of 3 groups:

  1. Group 1 will receive the Mediterranean lifestyle education resource on one occasion at baseline

  2. Group 2 will receive the Mediterranean lifestyle education resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian

  3. Group 3 will receive standard care (control group). Participants will receive the Mediterranean lifestyle education resource after their final 6 month study visit (i.e. delayed intervention).

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Development and Pilot Testing of Tailored Mediterranean Lifestyle Education to Encourage Behaviour Change in Patients With Mild Cognitive Impairment
Actual Study Start Date :
May 1, 2017
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Jun 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1: "ThinkMed" resource at baseline

The "ThinkMed" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards. Participants will receive this resource on one occasion at baseline (n=20)

Behavioral: "ThinkMed" resource at baseline
The "ThinkMed" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards. Participants will receive this resource on one occasion at baseline.

Experimental: Group 2: "ThinkMed" resource (staged)

This group of participants will receive the "ThinkMed" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian (n=20)

Behavioral: "ThinkMed" resource (staged)
This group of participants will receive the "ThinkMed" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian

Placebo Comparator: Group 3: Standard Care (control) group

Participants will continue with the standard care provided by their physician. Participants will receive the "ThinkMed" resource after their final 6 month study visit (i.e. delayed intervention) (n=20)

Behavioral: Standard Care Control
Participants will continue with the standard care provided by their physician. Participants will receive the "ThinkMed" resource after their final 6 month study visit (i.e. delayed intervention).

Outcome Measures

Primary Outcome Measures

  1. Change in Mediterranean Diet Score (MDS) at 6 months [Baseline, 6 months]

    Mediterranean dietary intake will be measured by a validated questionnaire

Secondary Outcome Measures

  1. Physical Activity [Baseline, 6 months]

    RPAQ-Recent Physical Activity Questionnaire

  2. Anthropometric measurements [Baseline, 6 months]

    Weight and height measurements to calculate BMI

  3. Muscle Strength [Baseline, 6 months]

    Measured using a grip-strength dynamometer

  4. Geriatric Depression Scale [Baseline, 6 months]

    Geriatric Depression Scale Questionnaire

  5. Functional Assessment (1) [Baseline, 6 months]

    Measured by the instrumental activities of daily living scale (IADL) by Lawton and Brody (1969) questionnaire

  6. Cognitive Assessment [Baseline, 6 months]

    A comprehensive cognitive assessment will be performed, including: global cognition, motor skills, executive function episodic/visual memory, and information processing and sustained attention using a validated neuropsychological test battery (Cantab Cognitive Battery, Cambridge Cognition Ltd.)

  7. Barriers to consuming a Mediterranean Diet questionnaire [Baseline, 6 months]

    Dietary behaviour change questionnaire to measure adherence to a Mediterranean diet

  8. Blood Sample [Baseline, 6 months]

    A blood sample will be taken from participants to be stored for analysis of biomarkers of MD adherence and biomarkers of neurodegenerative disease risk.

  9. Functional Assessment (2) [Baseline, 6 months]

    Measured by the Bristol activities of daily living scale (Bucks et al. 1996) questionnaire

  10. 4-day Food Diary [Baseline, 6 months]

    A food diary will be completed to assess compliance with a Mediterranean diet

  11. Change in Lifestyle questionnaire [Baseline, 6 months]

    A questionnaire to measure change in lifestyle behaviours

  12. Dietary Quality of Life questionnaire [Baseline, 6 months]

    A questionnaire to measure dietary quality of life

  13. Mediterranean Diet Knowledge questionnaire [Baseline, 6 months]

    A questionnaire to measure participants Mediterranean diet knowledge

  14. Rand SF-36 HEALTH SURVEY [Baseline, 6 months]

    A questionnaire to measure participants views and beliefs on health

  15. Staging Algorithm Questionnaire [Baseline, 6 months]

    A questionnaire to measure participants readiness to change their diet and lifestyle

  16. Mediterranean Diet self-efficacy questionnaire [Baseline, 6 months]

    A questionnaire to measure participants self-efficacy

  17. Mediterranean diet tolerance questionnaire [Baseline, 6 months]

    A questionnaire to measure tolerance to a Mediterranean diet

Other Outcome Measures

  1. Process Evaluation (1) - telephone contact evaluation [up to 3 months post intervention]

    Determination individual participation and engagement with the intervention by reviewing telephone contact log record and telephone checklist evaluation

  2. Process Evaluation (2) - study records [up to 3 months post intervention]

    A review of study records- including attrition rates, reason for dropout

  3. Process Evaluation (3) - structured interviews [up to 3 months post intervention]

    Post intervention structured interviews for participant evaluation of the intervention programme and dietary educational materials

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

  • Diagnosis of Mild Cognitive Impairment by their physician

  • Mediterranean diet score (MDS) less than or equal to 4 (Estruch et al., 2006)

  • Willing to make changes to their diet

Exclusion Criteria:
  • Diagnosis of dementia

  • Patients with visual or English language impairment

  • Psychiatric problems

  • Significant medical comorbidity

  • Body Mass Index (BMI) ≤ 19 and ≥ 40 kg/m2

  • Excessive alcohol consumption

  • Taking high dose nutritional supplements

  • Dietary restrictions/allergies that would substantially limit ability to complete study requirements

  • Inability to provide informed consent

  • History of, or comorbid condition which may alter performance on cognitive tests e.g. stroke, head injury, Parkinson's disease, learning disability

Contacts and Locations

Locations

Site City State Country Postal Code
1 Belfast Health and Social Care Trust Belfast United Kingdom BT9 7AB

Sponsors and Collaborators

  • Queen's University, Belfast
  • Wellcome Trust

Investigators

  • Principal Investigator: Jayne Woodside, PhD, Queens University Belfast

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jayne Woodside, PhD, Professor, Queen's University, Belfast
ClinicalTrials.gov Identifier:
NCT03265522
Other Study ID Numbers:
  • 16/NI/0105
First Posted:
Aug 29, 2017
Last Update Posted:
Nov 4, 2019
Last Verified:
Nov 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jayne Woodside, PhD, Professor, Queen's University, Belfast
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 4, 2019